Wikidata

(Q57635513)

English

Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study

article

In more languages

Statements

title
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
26027630
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26027630%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 February 2020

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q57635513&oldid=1937805786"